Beijing, China

Liangzhi Xie

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2024-2025

where 'Filed Patents' based on already Granted Patents

4 patents (USPTO):

Title: Innovations by Inventor Liangzhi Xie

Introduction

Liangzhi Xie is an accomplished inventor based in Beijing, China, known for his significant contributions to the field of biopharmaceuticals. With a portfolio of three patents, he has made strides in developing innovative therapies targeting critical health challenges.

Latest Patents

Xie's most recent patents showcase his expertise in immunotherapy and vaccine development. The first, titled "Humanized anti-PD-1 antibody and the use thereof," presents a recombinant humanized monoclonal antibody against the programmed cell death receptor-1 (PD-1). This groundbreaking invention has potential applications in tumor or cancer immunotherapy and includes nucleic acid sequences, vectors, pharmaceutical compositions, and kits.

Additionally, his patent "Chimeric papilloma virus L1 protein" pertains to chimeric proteins and polynucleotides that enhance HPV vaccine efficacy. This invention incorporates an N-terminal fragment from a first papilloma virus type, maintaining immunogenicity, alongside a C-terminal fragment from a second type, which offers better solubility and expression levels for mass production of vaccines.

Career Highlights

Liangzhi Xie is currently affiliated with Sinocelltech Ltd., where he applies his innovative thinking to address pressing medical challenges. His work has not only contributed to the advancement of therapies but has also established him as a key player in his field.

Collaborations

Throughout his career, Xie has collaborated with notable coworkers such as Chunyun Sun and Juan Ma. These partnerships have enabled him to leverage collective expertise and foster innovation within his research endeavors.

Conclusion

Liangzhi Xie exemplifies the spirit of innovation in the medical field, with patents that pave the way for advancements in cancer treatment and vaccine development. His work continues to impact healthcare positively, and his collaborations further enhance the potential for future breakthroughs in biopharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…